Genetic susceptibility to gastric cancer in Latin America
拉丁美洲胃癌的遗传易感性
基本信息
- 批准号:7458970
- 负责人:
- 金额:$ 5.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidityAcidsAddressAdenocarcinomaAdmixtureApoptosisAppearanceAtrophicAtrophic GastritisBiopsy SpecimenBrazilCancer EtiologyCancer PatientCandidate Disease GeneCarcinogensCellsCessation of lifeChronicClinicalClinical DataComplexConfounding Factors (Epidemiology)DataDevelopmentDiseaseDysplasiaEnvironmental Risk FactorEnzymesEpithelial Cell ProliferationEpithelial CellsEventGastric AdenocarcinomaGastric Intestinal Type AdenocarcinomaGastric Intraepithelial NeoplasiaGastric Parietal CellsGastritisGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenotypeGoalsHaplotypesHelicobacter InfectionsHelicobacter pyloriHigh PrevalenceHistopathologyHumanIL8 geneIL8RA geneIL8RB geneImmune responseImmunityIncidenceIndividualInfectionInflammatoryInflammatory ResponseInterleukin-8Intestinal MetaplasiaLatin AmericaLesionMalignant NeoplasmsMeasuresMediatingModelingMolecularMutagenesisPTGS2 genePathogenesisPatientsPatternPeruPopulationPredispositionPremalignantPrincipal InvestigatorProductionProtocols documentationRecruitment ActivityRiskRoleSamplingSomatic MutationSouth AmericaStagingStomachSymptomsTLR2 geneTNF geneTestingToll-Like Receptor 2Toll-like receptorsVariantangiogenesisbasecarcinogenesiscase controlcyclooxygenase 2cytokinegenetic associationgenetic epidemiologygenetic variantmalignant stomach neoplasmmodel developmentmonocyteneutrophilpathogenresponse
项目摘要
DESCRIPTION (provided by applicant): Gastric adenocarcinoma, the second cause of cancer-related deaths in Latin America, is associated with the high prevalence of infection with the type I carcinogen Helicobacter pylori. Several immunological events are associated with the inflammatory response in the stomach of infected individuals, which is associated with gastric carcinogenesis. This response is mediated by the Toll-like-receptors, pro-inflammatory cytokines such as interleukin-8 (IL8), 1L-1? and TNF-?, and the pro-inflammatory enzyme COX-2. Correa has proposed a progression model for the development of intestinal-type gastric adenocarcinoma, originally based on histopathology observations, but consistent with the effects of the pro-inflammatory immune response against H. pylori infection. However, there is substantial inter-individual variation in this progression, as well as in symptoms and clinical manifestations of carcinogenesis. Part of this variability is due to host genetic factors. The main goal of this proposal is to test the hypothesis that host genetic variants in TLR2, COX2, IL1B, ILRB, IL8 and IL8RA which are key components of the immune response against H. pylori infection, are associated with susceptibility to gastric adenocarcinoma in Peruvian and Brazilian admixed populations. We propose to perform a case-control association to with the following specific aims: (1) To collect clinical data and DMA samples of 860 gastric adenocarcinoma patients and 860 controls, 500 matched pairs from Lima (Peru) and 360 matched pairs from Rio de Janeiro (Brazil). (2) To quantify the levels of COX-2 and IL-8 in the stomach of gastric cancer patients and in a subset of controls by immunohistochemical analysis of biopsy specimens. (3) To identify the most informative set of tag-SNPs in TLR2, COX2, IL1B, ILRB, IL8, IL8RA and IL8RB to be used in genetic association studies in the selected populations and (4) To test the statistical association among haplotypes of TLR2, COX2, IL1B, ILRB, IL8 and IL8RA and: (a) levels of IL-8 and COX-2 in the stomach and (b) gastric adenocarcinoma, controlling for the effect of potential confounding variables such as admixture. We propose to develop a multi-centric study using a gene-candidate approach, capitalizing data demonstrating the role of the selected genes in the pathogenesis of gastric adenocarcinoma. By performing the study in Lima and Rio de Janeiro, we address the key issue of replication of genetic association studies.
描述(由申请人提供):胃腺癌是拉丁美洲与癌症相关死亡的第二个原因,与I型癌型幽门螺杆菌的高感染率有关。几个免疫事件与感染个体的胃中的炎症反应有关,这与胃癌发生有关。这种反应是由促炎细胞因子(例如白介素-8(IL8),1L-1)介导的。和TNF-?和促炎酶COX-2。科雷亚(Correa)提出了一个进展模型,用于开发肠道胃腺癌的发展,最初是基于组织病理学观察到的,但与促炎症性幽门螺杆菌感染的促炎性免疫反应的影响一致。但是,这种进展以及癌变的症状和临床表现存在很大的个体差异。这种变异的一部分是由于宿主遗传因素引起的。该提案的主要目的是检验以下假设:TLR2,COX2,IL1B,ILRB,IL8和IL8RA中的宿主遗传变异是针对幽门螺杆菌感染的免疫反应的关键组成部分,与对胃腺癌对佩里氏症和巴西脂肪症的易感性有关。我们建议与以下特定目的进行病例对照关联:(1)收集860例胃腺癌患者和860个对照组的临床数据和DMA样品,来自利马(秘鲁)的500对匹配和360对匹配的对,来自巴西Rio de Janeiro(巴西)。 (2)通过对活检标本的免疫组织化学分析来量化胃癌患者胃的COX-2和IL-8水平。 (3) To identify the most informative set of tag-SNPs in TLR2, COX2, IL1B, ILRB, IL8, IL8RA and IL8RB to be used in genetic association studies in the selected populations and (4) To test the statistical association among haplotypes of TLR2, COX2, IL1B, ILRB, IL8 and IL8RA and: (a) levels of IL-8 and胃中的COX-2和(b)胃腺癌,控制潜在混杂变量(例如混合)的影响。我们建议使用基因候选方法进行多中心研究,并资本化数据,证明了所选基因在胃腺癌发病机理中的作用。通过在利马和里约热内卢进行研究,我们解决了遗传关联研究复制的关键问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eduardo M Tarazona-Santos其他文献
Eduardo M Tarazona-Santos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eduardo M Tarazona-Santos', 18)}}的其他基金
Genetic susceptibility to gastric cancer in Latin America
拉丁美洲胃癌的遗传易感性
- 批准号:
7290567 - 财政年份:2007
- 资助金额:
$ 5.08万 - 项目类别:
Genetic susceptibility to gastric cancer in Latin America
拉丁美洲胃癌的遗传易感性
- 批准号:
7669159 - 财政年份:2007
- 资助金额:
$ 5.08万 - 项目类别:
Genetic susceptibility to gastric cancer in Latin America
拉丁美洲胃癌的遗传易感性
- 批准号:
8133791 - 财政年份:2007
- 资助金额:
$ 5.08万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Metabolic determinants of Staphylococcus aureus skin colonization
金黄色葡萄球菌皮肤定植的代谢决定因素
- 批准号:
10749745 - 财政年份:2023
- 资助金额:
$ 5.08万 - 项目类别:
Mechanical Modulation of Cell Migrations by DNA Nanoassemblies
DNA 纳米组件对细胞迁移的机械调节
- 批准号:
10659333 - 财政年份:2023
- 资助金额:
$ 5.08万 - 项目类别:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10518247 - 财政年份:2022
- 资助金额:
$ 5.08万 - 项目类别:
The trigger and homeostatic function of a novel immune-sebum circuit
新型免疫皮脂回路的触发和稳态功能
- 批准号:
10662229 - 财政年份:2022
- 资助金额:
$ 5.08万 - 项目类别:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10707541 - 财政年份:2022
- 资助金额:
$ 5.08万 - 项目类别: